Yahoo Finance Live anchor Seana Smith highlights which tickers are making moves in after-hours trading.
The Covid-19 vaccine maker reported a net loss of more than $169 million for the third quarter, compared to a loss of $322 million in the same period last year.
Novavax will face a pivotal moment late Tuesday as NVAX stock investors watch to see whether the firm can turnaround a third-quarter profit. The post The Make-Or-Break Moment For Novavax: What To Watc
Novavax Inc. NVAX, +0.15% said Tuesday a late-stage trial of its vaccine targeting the COVID variant omicron supports its continued and future use as a booster. The company said the Phase 3 trial met
Although an uncomfortable subject based on financial sensitivities, the topic of Nasdaq stocks to avoid cannot be avoided much longer. To be clear, it's not so much about the companies specifically.
With the Fed signaling oversized rate hikes for longer is the likely trajectory moving forward, it is understandable why investors are looking for stocks to sell rather than stocks to buy. Consumer sp

Biotech And XBI: The Bottom Is In

07:19am, Tuesday, 01'st Nov 2022 Seeking Alpha
XBI is a widely diversified ETF comprised of myriad small and midcap biotech stocks. Read how I've built up a large position in the ETF since mid-June.

Earnings Preview: Qiagen (QGEN) Q3 Earnings Expected to Decline

02:00pm, Monday, 31'st Oct 2022 Zacks Investment Research
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Could This Bullish News Make Novavax a Hot Buy?

09:53am, Thursday, 27'th Oct 2022
Can this turn the stock's fortunes around?
While COVID vaccinations are shrinking, it's still a multi-billion market opportunity. Novavax is sitting on a mountain of cash and its vaccine is already a blockbuster.
Small-cap stocks are usually young companies that aspire to become large-cap or mega-cap one day.

Why Novavax Stock Rose 12.57% on Friday

06:44pm, Friday, 21'st Oct 2022
Investors did an about-face after the stock slumped earlier in the week.
Stocks were set to open lower today, but the market seems to have found its groove. Everything from tech stocks to vaccine stocks are moving higher.
Novavax (NVAX) gets FDA authorization for using its COVID vaccine as a booster dose in adults after six months of completing the primary vaccine regimen.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE